Inside Big Pharma’s Stealth War on Drug Price Watchdog: Reuters Special Report September 11, 2020 By Caroline Humer As evidence grew this spring that the drug remdesivir was helping COVID-19 patients, some Wall Street investors bet on analysts’...
Insurers Lobby for Clarity as Republicans Move to Repeal Obamacare December 8, 2016 By Caroline Humer The largest lobbying group for health insurers has asked U.S. lawmakers weighing the fate of Obamacare to push back the...
Study: 43% of Insurers’ Prescription Payments Going to Specialty Drugs July 12, 2016 By Linda A. Johnson The latest study of medicine prices finds U.S. insurers’ spending on expensive prescription drugs nearly quadrupled from 2003 through 2014,...
Health Insurers Working to Improve Provider Network Directories March 24, 2016 By Tom Murphy Some health insurers are hoping to ease headaches that can flare when customers try to confirm whether a doctor is...
Parrot Bite? In-Law Woes? Whatever the Health Claim, There’s an Insurance Code October 6, 2015 By John Lauerman There are 70,000 ways to get sick, hurt or mortally injured, and the U.S. is making them official. Last Thursday,...
Insurers, Drugmakers Tussle Over Drug Copay Caps March 13, 2015 By Alex Wayne The battle over soaring U.S. drug prices is heading for the states. With the price of some treatments topping $100,000,...
In Supreme Court Briefs, Big Business Supports Obamacare Subsidies February 12, 2015 By Paul Barrett The Supreme Court briefs are in, and we can now say that big business backs Obamacare. The justices will hear...
Insurers Balk at High Cost of Specialty Drug May 21, 2014 The leading U.S. health insurance trade group on Tuesday hit out at the extremely high cost of new specialty medicines,...
Rate Cap for Older Insureds to Mean Higher Health Insurance Costs for Younger February 25, 2013 By David Morgan The Obama administration on Friday finalized new consumer safeguards for health insurance that impose tighter restrictions on what insurers can...